[{"id":"38586fe8-a3bb-493e-ab3e-daaa8e0d3984","acronym":"","url":"https://clinicaltrials.gov/study/NCT05212987","created_at":"2022-01-29T18:05:39.593Z","updated_at":"2024-07-02T16:36:17.854Z","phase":"Phase 1","brief_title":"Study of FCN-098 in Patients With Advanced Solid Tumor","source_id_and_acronym":"NCT05212987","lead_sponsor":"Fochon Pharmaceuticals, Ltd.","biomarkers":" NTRK","pipe":" | ","alterations":" NTRK positive • NTRK fusion","tags":["NTRK"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NTRK positive • NTRK fusion"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FCN-098"],"overall_status":"Recruiting","enrollment":" Enrollment 43","initiation":"Initiation: 12/31/2021","start_date":" 12/31/2021","primary_txt":" Primary completion: 05/08/2024","primary_completion_date":" 05/08/2024","study_txt":" Completion: 10/12/2024","study_completion_date":" 10/12/2024","last_update_posted":"2022-01-28"}]